Purchase Order SPE2DP26P0640

<p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Fenwal, Inc. for blood packs with anticoagulant, valued at $2,334.42, with an award date of March 25, 2026 and ultimate completion date of June 23, 2026. Work is performed in Lake Zurich, Illinois. This is a firm fixed-price purchase order with no set-aside.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a purchase order to Fenwal, Inc. on February 5, 2026, for blood packs with anticoagulant, valued at $2,334.42. No set-aside was used. Performance takes place at Fenwal's facility in Lake Zurich, Illinois. The order closes February 10, 2026.</p>

The U.S. government awarded a firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $85,899.84 contract is to provide blood packs with anticoagulant to the Defense Logistics Agency (DLA), which serves as the medical supply chain for the U.S. Department of Defense. The contract has an ultimate completion date of July 21, 2025 and was awarded on May 22, 2025. Fenwal, Inc. is a registered...

Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...

<p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Fenwal, Inc. valued at $4,430.03 for diluting solution, with an award date of March 24, 2026 and ultimate completion date of March 31, 2026. No set-aside was used. Performance occurs in Lake Zurich, Illinois. The order is priced on a firm fixed-price basis for commercial medical supply items supporting federal blood banking and transfusion operations.</p>

The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order valued at $3,967.24 to Fenwal, Inc. for a hand blood sealer on November 7, 2025, with an ultimate completion date of December 1, 2025. The contract, issued without set-aside designation, reflects Fenwal's established position as a specialized supplier of blood collection, separation, storage, and transfusion products to federal health agencies. Fenwal, a subsidiary of Fresenius Kabi headquartered...

The Defense Logistics Agency Medical Supply Chain awarded a $3,581.75 firm fixed-price purchase order to Fenwal, Inc. for washing solution on January 27, 2026, with an ultimate completion date of May 27, 2026. This contract carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for this critical blood banking consumable. Fenwal, a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a global blood technology company that...

<p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Fenwal, Inc. for anticoagulant citrate products on March 10, 2026, with a ceiling value of $2,428.32. Performance is to be completed by March 16, 2026, and work is performed in Lake Zurich, Illinois.</p>

The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...